Glucerna

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glucerna

Quick Facts

Property Description
Active component Modified Carbohydrate Blend (multinutrient composite)
Form Liquid Formula (Ready-to-Drink) or Powder
Pharmacological class Enteral Nutrition Preparation
Common use Dietary Management of Diabetes Mellitus
Origin Synthetically and Naturally Derived Composite

What Type of Formula is Glucerna? (Identity and Class)

Glucerna is a Specialized Nutritional Formula and a Combination Product that belongs to the pharmacological class of Enteral Nutrition Preparation. It is a Food For Special Diets designed for the specific nutritional management of a disease or condition, often fitting the definition of a Medical Food in certain regulatory contexts. The product is developed and manufactured by Abbott Nutrition, focusing on adults and older adolescents with specialized nutritional needs. The formula is available in multiple Dosage form(s), primarily as a ready-to-use Liquid Formula (Ready-to-Drink Preparation) or a Powder for Reconstitution, facilitating a dual Route of administration via either oral consumption or clinical Enteral (Tube) Feeding.

Composition and Specialized Nutritional Design

The formula is a Synthetically and Naturally Derived Composite composed of essential Macronutrients and a full profile of Micronutrients (Vitamins and Minerals). Its defining characteristic is a proprietary Modified Carbohydrate Blend, which is engineered to ensure a Low Glycemic Index. This specialized blend is designed for its ability to deliver nutrients that help mitigate sudden glucose spikes. The blend is paired with high-quality protein, Dietary Fiber, and specialized fats, such as Monounsaturated Fatty Acids.

General Purpose: Glycemic Support and Complete Nutrition

The general therapeutic purpose of Glucerna is to provide comprehensive Nutritional Support while facilitating Glycemic Control Support. By promoting Sustained Energy Release, the product helps manage the blood glucose response, a scenario often required for individuals with Impaired Glucose Tolerance or those needing assistance with the Dietary Management of Diabetes Mellitus when consuming a regular diet is not feasible. The formula serves to ensure that highly specialized, disease-specific nutrition is consistently delivered.

Regulatory References

  1. VA National Formulary

What side effects are possible with Glucerna?

Glucerna: Possible Side Effects and Safety Information

Glucerna is a brand of nutritional products designed to be used under medical supervision as part of a diabetes management plan. As a specialized medical food/supplement, its safety profile is defined primarily by appropriate use, specific contraindications, and potential for common mild side effects.


Adverse Reaction Scope

Category Details
Common Side Effects Mild gastrointestinal side effects may occur, including diarrhea, gas, and bloating. These are typically associated with nutritional supplements and may relate to ingredients like sweeteners or fiber.
Serious Adverse Reactions No specific serious adverse reactions from the product itself are listed in standard regulatory summaries. The most significant risks are associated with misuse (e.g., using it inappropriately for acute medical conditions or through unauthorized routes).
Allergy & Intolerance Glucerna products contain milk and soy ingredients. Some formulations are suitable for most individuals with lactose intolerance and are gluten-free, but they are not suitable for individuals with galactosemia.

Safety Restrictions and Contraindications

Restriction Type Official Safety Note
Absolute Contraindication Not for use in individuals with galactosemia.
Route of Administration Not for intravenous (IV) use or for use as a sole-source tube feed unless specified by a healthcare professional.
Acute Conditions Not to be used to treat hypoglycemia (low blood sugar), insulin shock, or insulin reaction, as the slow-digesting carbohydrates are inappropriate for rapid blood glucose restoration.
Pediatric Use Not recommended for children (ages 1–13) as nutrient levels are formulated for adults, which may exceed safe upper limits for the younger population.
Drug Interactions Individuals taking blood-thinning medications should consult their physician regarding the product's Vitamin K or Vitamin E content.

Regulatory Safety Summary

The regulatory context for Glucerna focuses on ensuring its use is safe and appropriate for its intended nutritional purpose. Key warnings emphasize that the product is for oral or enteral use only, must be used under medical supervision, and is not a replacement for prescribed diabetes medication or a complete substitute for a varied, healthy diet.

Overdose and Emergency Response

Overdose and When to Seek Help

Glucerna is a Specialized Nutritional Formula, and its official regulatory profile focuses on the physiological consequences of over-ingestion rather than typical drug toxicology. The primary concerns documented in regulatory statements relate to metabolic and volume stability.

Documented Overdose Manifestations

Over-ingestion of the formula is documented to present with symptoms related to caloric and volume overload. These include Gastrointestinal Distress, such as nausea, vomiting, diarrhea, and abdominal distention. A significant concern, due to the specialized carbohydrate blend, is Metabolic Imbalance, specifically sustained Hyperglycemia or severe Fluid and Electrolyte Imbalances [NIH MedlinePlus].

Required Emergency Actions

Regulatory documents state that Immediate Medical Attention or Emergency Services Contact is required if persistent or severe manifestations of over-ingestion occur, or if signs of profound metabolic derangement are observed. Regulators mandate consulting a certified Poison Control Center for specific guidance on formula over-ingestion.

Management and Monitoring

Management procedures involve Symptomatic and Supportive Treatment, focusing on the correction of fluid, electrolyte, and glucose imbalances. Hospital monitoring may be required to observe and manage these levels. Consistent with a nutritional preparation, no specific antidote is known or documented in the official labeling. Over-ingestion risk requires increased vigilance in individuals with conditions like Renal or Cardiac Impairment.

Therapeutic Uses of Glucerna

What Glucerna Treats: Main Uses and Benefits

Glucerna is a specialized nutritional formula considered relevant for the dietary management of glucose metabolism disorders. This generally includes Type 1 and Type 2 Diabetes Mellitus, as well as prediabetic states such as Impaired Glucose Tolerance. Its use is relevant in clinical settings marked by increased discomfort or tension where patients need specialized nutritional input.

It is applied when appropriate in addressing conditions involving episodic or fluctuating manifestations related to diet, and is commonly used to help with the long-term dietary management of chronic glucose disorders. This application may assist with supporting patients during difficult episodes by contributing to easing the overall symptom load related to dietary inconsistencies.

Glucerna is used for managing symptoms related to heightened physiological activity, specifically symptoms that create noticeable physiological strain after nutritional intake. This product is applied in addressing symptoms that interfere with daily comfort. The formula contributes to improved comfort during periods of heightened symptoms, particularly when dealing with inconsistent nutrient intake and the risk of malnutrition.


Quick Fact: Relief for Postprandial Symptoms
Glucerna is applied when symptoms are driven by the body's digestive and metabolic response to food, assisting with maintaining a sense of stability when symptoms are more noticeable.

Regulatory References

  1. VA Glucerna Therapeutic Shake Criteria for Use August 2023

Eligibility and Restrictions for Use

Who Can and Cannot Use Glucerna?

This section outlines the official population eligibility and contraindications for Glucerna, a specialized nutritional formula, as established by government regulatory authorities.


Eligibility Scope

Classification Details
Populations for whom use is allowed Individuals with Diabetes Mellitus (Type 1 or Type 2) or Impaired Glucose Tolerance. Designed primarily for adult nutrition needs .
Populations for whom use is contraindicated Individuals with Galactosemia (an absolute metabolic contraindication). Not for intravenous (IV) use (parenteral administration is prohibited).
Age-related eligibility rules Primarily intended for adults 18 years of age or older. Use has not been evaluated or is not recommended for children.
Condition-specific eligibility rules Use is not recommended for the treatment of acute hypoglycemia. Patients with Chronic Kidney Disease (CKD) require assessment by a specialist before use.
Pregnancy and lactation eligibility Safe for use by pregnant women with existing diabetes or gestational diabetes, but professional consultation is required to monitor supplemental nutrient intake.

Official Regulatory Summary

Glucerna’s eligibility profile is defined by two key exclusions: it is strictly contraindicated for patients with Galactosemia and must not be used intravenously. The formula is specifically intended for the dietary management of glucose metabolism disorders in adults and is not recommended for minors. While suitable for diabetic women who are pregnant or nursing, use should always be managed under the guidance of a healthcare professional.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Glucerna is a Specialized Nutritional Formula and its interaction profile is structured around two key patterns: physical interference with absorption and pharmacodynamic effects from its nutrient content. The official interaction classification primarily involves Clinically Significant Interactions that require monitoring or timing separation, rather than strict contraindications.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Substance/Class Official Regulatory Statement
Absorption Interference Quinolone Antibiotics (e.g., Ciprofloxacin) Co-administration with enteral formulas may reduce the oral absorption of the antibiotic, requiring mandatory timing separation of administration.
Absorption Interference Thyroid Preparations (e.g., Levothyroxine) The formula's soy-containing component may interfere with drug absorption, necessitating separation of administration timing to mitigate reduced systemic exposure.
Pharmacodynamic Antagonism Vitamin K Antagonists (e.g., Warfarin) The Vitamin K content of the formula may antagonize the anticoagulant effect of Warfarin, requiring close monitoring of the International Normalized Ratio (INR).
Pharmacodynamic Addition Antidiabetic Agents (e.g., Insulin, Oral Hypoglycemics) The formula's low-glycemic design provides an additive glycemic effect to these prescription medications, which must be accounted for during concurrent administration.

The overall regulatory profile emphasizes that administration of the nutritional formula must be considered as a source of drug-nutrient interaction for medications with a narrow therapeutic window or those susceptible to binding with multivalent cations.

Mechanism of Action

Glucerna's specialized formulation influences metabolic signaling through three core mechanistic domains, each affecting distinct biological processes that result in modulated physiological activity.

Modulation of Carbohydrate Digestion and Absorption

This mechanism involves the product's unique blend of slow-digesting carbohydrates and fiber, which modulate enzymatic breakdown and nutrient transport across the intestinal lining. This action limits the speed at which glucose enters the bloodstream, resulting in a slower and less rapid increase in post-prandial glucose concentration.

Modulation of Cellular Glucose Response Pathways

Specific components, such as certain fatty acids and myo-inositol, are included to affect pathways associated with insulin signaling and cellular uptake. This action promotes the uptake and utilization of circulating glucose by peripheral tissues, thereby influencing the overall metabolic requirement to clear glucose from the blood.

Influence on Satiety Signaling and Energy Delivery Dynamics

The formula's specific ratio of protein, fiber, and healthy fats (monounsaturated/polyunsaturated) acts on the GI tract and associated signals to provide a gradual, extended release of energy. The prolonged presence of metabolic fuel in the circulation influences satiety signals and extends the duration of nutrient-mediated feedback.

Dosage and Administration Information

How to Use Glucerna

The usage of Glucerna, a specialized nutritional formula, is structured around official administration protocols and serving guidelines established in authoritative documents. Its use is always required to be under medical supervision.


Administration Routes and Standard Servings

The formula has two approved pathways for nutrient delivery. It is administered via oral consumption when used as a supplement or meal replacement, or via enteral (tube) feeding when indicated for total nutrition. The formula is not approved for intravenous (IV) delivery. The standard single serving volume for oral consumption is typically 8 fl oz (approx 237 mL).

Dosing Patterns and Frequency

When used as an oral supplement, consumption typically involves one to two servings per day as part of a balanced diet. For enteral administration, the total volume and flow rate must be clinically adjusted according to the patient’s condition and tolerance; explicit, fixed dosing schedules (like those for pharmaceuticals) are not provided in official labels. Glucerna is suitable for both short-term nutritional support and long-term dietary management.

Preparation and Handling

Prior to use, liquid containers must be shaken well. If using the powder form, it requires reconstitution with cooled water. For both oral and tube feeding, the formula may be administered at room temperature. Any opened formula must be promptly refrigerated and consumed within 48 hours to maintain product integrity. Additionally, when used for tube feeding, extra water must be provided between or after feedings to meet fluid requirements.

Recent Clinical Evidence

Glucerna is a brand of diabetes-specific nutritional formulas (DSNFs) designed to provide balanced nutrition and a specific carbohydrate profile. Its formulation includes a unique blend of slow-digesting carbohydrates, high-quality protein, monounsaturated fatty acids (MUFAs), and a range of essential vitamins and minerals.

Clinical Findings on Glycemic Response

The majority of research has focused on the formula’s impact on postprandial glucose response (blood sugar levels after eating). Clinical studies, including randomized controlled trials, consistently show that consumption of Glucerna results in a significantly lower and slower rise in blood glucose and insulin levels compared to high-glycemic carbohydrates or standard nutritional supplements.

  • Postprandial Control: Studies in adults with type 2 diabetes have found that using Glucerna as a meal or snack replacement helps to minimize postprandial glucose excursions.
  • HbA1c and Management: Some longer-term trials have observed that incorporating Glucerna into a comprehensive diabetes management plan is associated with improvements in measures of long-term control, such as a reduction in HbA1c levels, in elderly patients who were malnourished or at risk for malnutrition.

Supporting Evidence on Weight and Body Composition

Beyond glucose control, research has examined the product's role in body composition, often in comparison to standard care:

  • Weight Management: In randomized controlled trials involving people with type 2 diabetes, the use of one to two servings of the product daily as a partial meal replacement was associated with a greater reduction in body weight and visceral fat mass compared to standard-of-care diet counseling alone.
  • Lean Mass: These same trials also observed an association between the supplement and a greater increase in lean body mass (including skeletal muscle) over a 90-day period.

Key Studies & References

  1. Effects of diabetes-specific nutrition formulas on body weight and composition in type 2 diabetes: a systematic review
  2. The role of diabetes-specific nutritional supplements in the management of type 2 diabetes mellitus: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Glucerna (FAQ)

Q: Is Glucerna a meal replacement or just a supplement?

Official product use guidance describes Glucerna products as suitable for use as either a nutritional supplement or as a full or partial meal replacement. The products are formulated to be nutritionally complete and are intended for use in supporting a balanced diet or as a meal replacement, as determined by the patient's nutritional plan.


Q: What is the difference between Glucerna shakes and other general nutrition shakes?

According to official formulation information, Glucerna is specifically distinguished from general nutrition shakes by its low-glycemic carbohydrate blend. This specialized blend is associated with modulating the blood sugar response following consumption, which is the primary focus for people managing diabetes.


Q: Can drinking Glucerna make you gain weight?

Official guidance often describes Glucerna as being incorporated into weight management plans for weight reduction. However, due to the caloric content, consumption that exceeds individual daily energy requirements may be associated with weight gain.


Q: Does Glucerna interact with common over-the-counter vitamins or mineral supplements?

Glucerna is fortified with a range of vitamins and minerals. Consultation with a healthcare professional regarding total nutrient intake is generally advised when combining Glucerna with other supplements. This practice helps to ensure balanced nutrition and mitigate the potential for over-consumption.


Q: What happens if I drink Glucerna every day?

According to the official product usage guidance, Glucerna is a complete and balanced nutritional product that is formulated to be suitable for use as a daily nutritional component. It is often used as a regular part of a structured diabetes management plan or to replace one to two snacks or meals per day.


Q: Can Glucerna replace a meal if I am too busy to eat?

Yes, official product guidance confirms that some Glucerna products are specifically designed and marketed as convenient meal replacements. The products are designed to deliver balanced nutrition and function as meal replacements for convenience.


Q: Does Glucerna contain sugar?

Official product labelling indicates that Glucerna products do contain sugar, although the specific amount can vary depending on the formula chosen. Some specific formulas are labelled to contain as little as one gram of total sugar per serving.


Q: Can Glucerna be consumed by someone who does not have diabetes?

Official product information states that while Glucerna is specially formulated for the dietary management of diabetes and pre-diabetes, it is a nutritionally complete and balanced beverage. The product's nutritional profile is generally suitable for consumption by adults, even those without diabetes.


Q: Does Glucerna need a prescription to be purchased?

Glucerna products are generally classified as specialized nutritional formulas and are available over-the-counter. They do not typically require a prescription for purchase. However, the product is designed and intended for use under medical supervision as part of a diabetes management plan.


Q: Does Glucerna contain artificial sweeteners?

According to the official ingredient lists, some Glucerna formulas, such as Glucerna Triple Care, do contain artificial sweeteners. These sweeteners are used in the formulation to provide sweetness while maintaining the product's nutritional goals.


Q: Can Glucerna be mixed with other liquids like coffee or water?

Official product preparation guidance indicates that Glucerna powder formulas can be mixed with water or other liquids. Some product information also shows that it is possible to incorporate the product into recipes, including hot beverages like coffee or tea. Official guidance includes specific preparation instructions for use with other liquids.


Q: Are there different formulas of Glucerna for Type 1 vs Type 2 diabetes?

Official product categorization indicates that the different Glucerna formulas are typically distinguished by features such as protein content, calorie density, and total sugar, rather than being specifically separated for Type 1 versus Type 2 diabetes. They are generally formulated for the overall dietary management of all individuals with diabetes or impaired glucose tolerance.


Q: Does Glucerna affect cholesterol levels?

Studies examined by clinical regulators have specifically looked at the potential effects of Glucerna’s low-glycemic liquid meal replacement on lipid (cholesterol) levels. Findings from one 3-month trial suggested that the use of the product did not affect lipid levels.


Q: What is the meaning of the GI (Glycemic Index) score related to Glucerna?

The Glycemic Index (GI) is a standard measure used in nutritional science to classify how carbohydrate-containing foods affect blood glucose levels after consumption. Glucerna products are formulated with a specialized low GI blend of carbohydrates. The low GI blend is associated with a slower blood sugar response compared to high-glycemic carbohydrates.

How should Glucerna be stored and disposed of?

Glucerna liquid formulas in unopened containers must be stored at room temperature and should avoid freezing or excessive heat. Once opened, the liquid product must be covered, refrigerated immediately, and consumed or discarded within 48 hours to maintain stability and prevent contamination. If the product is sipped directly from the container, it must be refrigerated and used within 24 hours. Powdered Glucerna must be stored in a cool, dry place (not refrigerated) after opening, and the contents must be used within three weeks. Unused or expired Glucerna should be properly discarded; regulatory guidelines recommend using a drug take-back program or following local waste disposal instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Glucerna found in:

A-Z Index: